Antiretroviral therapy for children in resource-limited settings: current regimens and the role of newer agents. - Wikidata - wikimedia - TriplyDB

Antiretroviral therapy for children in resource-limited settings: current regimens and the role of newer agents.

Antiretroviral therapy for children in resource-limited settings: current regimens and the role of newer agents.

http://www.wikidata.org/entity/Q37925813

about

Sequencing paediatric antiretroviral therapy in the context of a public health approach Getting to 90-90-90 in paediatric HIV: What is needed?Predictors of virologic and clinical response to nevirapine versus lopinavir/ritonavir-based antiretroviral therapy in young children with and without prior nevirapine exposure for the prevention of mother-to-child HIV transmission.Pediatric response to second-line antiretroviral therapy in South Africa High levels of virological failure with major genotypic resistance mutations in HIV-1-infected children after 5 years of care according to WHO-recommended 1st-line and 2nd-line antiretroviral regimens in the Central African Republic: A cross-section Early outcomes of darunavir- and/or raltegravir-based antiretroviral therapy in children with multidrug-resistant HIV at a pediatric center in Botswana.Raltegravir: a review of its use in the management of HIV-1 infection in children and adolescents.

P2860

Q26774261-1BF4DDCF-6CB8-478A-A09E-AEBC7B3C9A45 Q30385352-B29A503A-427D-4F79-81DE-660BED2868A6 Q34200009-678376F5-7A2F-4556-9AE1-138696E724F0 Q34490216-2B5CE19B-5FB5-46ED-817D-219C7C971464 Q37696892-F3A2B28D-5399-4423-B483-BD3E19C0F054 Q38073734-E3D942B2-86B3-4679-B98C-1A925A228B61 Q38166286-349A179D-0800-44B2-9413-E29C16772584

P2860

Antiretroviral therapy for children in resource-limited settings: current regimens and the role of newer agents.

http://www.wikidata.org/entity/Q37925813

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Antiretroviral therapy for chi ...... and the role of newer agents.

@en

Antiretroviral therapy for chi ...... and the role of newer agents.

@nl

type

label

Antiretroviral therapy for chi ...... and the role of newer agents.

@en

Antiretroviral therapy for chi ...... and the role of newer agents.

@nl

prefLabel

Antiretroviral therapy for chi ...... and the role of newer agents.

@en

Antiretroviral therapy for chi ...... and the role of newer agents.

@nl

P1433

Q37925813-9DBD9384-A044-4377-884C-AFC38CD53442

P1476

Q37925813-1A48289C-55D8-43DA-BADE-3500AA4CB0F4

P2093

Q37925813-2AC395A6-0B1D-4347-A50F-D48F86D6F86C

Q37925813-E1963105-951B-4163-9B78-C06732410965

P2860

Q37925813-04A2EA75-C1A2-4F8F-8330-D9C3B86F1CAC

Q37925813-061E8635-02B5-446E-9953-01EB75D50BE0

Q37925813-0A3CE279-7FD8-4A1D-AEDA-1D0DE9D6AFCF

Q37925813-0C7253BD-7615-4DC4-9381-E6D1AB2FB15E

Q37925813-0E2CDFE2-F35B-4F0B-B83A-EC566349C25F

Q37925813-128020CD-CACE-4315-84BD-9BA57A716353

Q37925813-12B47EA9-CA09-40EF-A0AA-833B7CD1D0F4

Q37925813-17BF9BA9-0682-44EC-828F-ADA41E7F7F61

Q37925813-180F6E45-9AF0-41C8-8A55-9BA9B6EBA33F

Q37925813-18B4356F-F61C-456C-821F-70B1F501EA24

P2888

Q37925813-CD167B2B-7546-411B-BF1B-38D32E16E78D

P304

Q37925813-45290BAB-4BC8-4CED-848E-DE113467B62A

P31

Q37925813-8EC68785-657E-46BB-BEAC-563CBEC6056A

P356

Q37925813-F90592B8-0747-4E97-A5A9-7DC105E4B950

P433

Q37925813-BB07742F-7E2E-4EA8-B81A-F02855E45CC0

P478

Q37925813-DB98023D-E484-4401-AB60-9D631846A8CD

P577

Q37925813-6A20147F-A038-4510-9F59-C0EF5BB24C2F

P5875

Q37925813-FB4B6563-3F02-4150-AC1B-D3A27A79AF88

P6179

Q37925813-2B8A75AF-EE2F-4934-AA2F-1B7B04F42DFD

P698

Q37925813-59DA92E1-62CE-4A78-8B40-5A187699958E

P921

Q37925813-9E04C353-3427-4660-BE9D-3C6A538BFF8D

P356

11593330-000000000-00000

P1433

Pediatric Drugs

P1476

Antiretroviral therapy for chi ...... and the role of newer agents.

@en

P2093

Brian S Eley

http://www.w3.org/2001/XMLSchema#string

Tammy Meyers

http://www.w3.org/2001/XMLSchema#string

P2860

A 12-month treatment with tenofovir does not impair bone mineral accrual in HIV-infected children.

Nevirapine resistance and breast-milk HIV transmission: effects of single and extended-dose nevirapine prophylaxis in subtype C HIV-infected infants

Population pharmacokinetics of lopinavir in combination with rifampicin-based antitubercular treatment in HIV-infected South African children.

Pediatric HIV clinical care resources and management practices in Asia: a regional survey of the TREAT Asia pediatric network.

Antiretroviral therapy outcomes in HIV-infected children after adjusting protease inhibitor dosing during tuberculosis treatment.

A chewable pediatric fixed-dose combination tablet of stavudine, lamivudine, and nevirapine: pharmacokinetics and safety compared with the individual liquid formulations in human immunodeficiency virus-infected children in Thailand.

Antiretroviral treatment for children with peripartum nevirapine exposure.

Efficacy and safety of darunavir-ritonavir compared with that of lopinavir-ritonavir at 48 weeks in treatment-experienced, HIV-infected patients in TITAN: a randomised controlled phase III trial.

Etravirine: a second-generation nonnucleoside reverse transcriptase inhibitor (NNRTI) active against NNRTI-resistant strains of HIV.

Virologic failure and second-line antiretroviral therapy in children in South Africa--the IeDEA Southern Africa collaboration.

P2888

11593330-000000000-00000

P304

303-316

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2165/11593330-000000000-00000

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P577

2011-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51611224

http://www.w3.org/2001/XMLSchema#string

P6179

1025041465

http://www.w3.org/2001/XMLSchema#string

P698

21888444

http://www.w3.org/2001/XMLSchema#string

P921

antiretroviral drug